| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_89ac64d62baaa791ac712c93832985fd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9053336f864c5a26dbb215cf18470db1 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D411-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D411-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 |
| filingDate |
2009-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd29b19608acdf9abb944527f291e95d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e15d85f8d8e0cc503da3418ad35a602
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ad602769d441e2a78d051bd8e03339c |
| publicationDate |
2011-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
BR-PI0903664-A2 |
| titleOfInvention |
Method of obtaining a new crystalline form of lamivudine, its monohydrate hydrochloride salt, pharmaceutical formulations and their uses |
| abstract |
METHOD OF OBTAINING A NEW CRYSTALLINE FORM OF LAMIVUDINE, ITS MONOHYDRATED CHLORIDRAATE SALT, PHARMACEUTICAL FORMULATIONS AND ITS USES. The present invention is intended for the method of obtaining a solid crystalline form of lamivudine, form VI, its hydrochloride salt monohydrate and its pharmaceutical formulations. In addition, the present application relates to the use of the crystalline forms of lamivudine monohydrate salt in the preparation of drugs indicated as an anti-HIV agent (acquired immunodeficiency syndrome - AIDS). |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9688666-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015368232-A1 |
| priorityDate |
2009-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |